| Date Filed | Type | Description |
| 08/02/2023 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 1,825 shares
@ $2.81, valued at
$5.1k
|
|
| 03/24/2023 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Bought 10,000 shares
@ $4.314, valued at
$43.1k
|
|
| 02/02/2023 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 1,172 shares
@ $10.2085, valued at
$12k
|
|
| 02/01/2023 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 105,000 options to buy
@ $12.88, valued at
$1.4M
Granted 37,100 restricted stock units
@ $0 |
|
| 01/03/2023 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Paid exercise price by delivering 3,028 shares
@ $16.45, valued at
$49.8k
Exercised 12,500 restricted stock units
@ $0 |
|
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
3
| Eisenstadt Richard I (CFO) has filed a Form 3 on Altimmune, Inc. |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2019 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Neos Therapeutics, Inc.|
Txns:
| Granted 230,276 options to buy
@ $2.31, valued at
$531.9k
|
|
| 12/13/2018 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Neos Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $2.1639, valued at
$10.8k
|
|
| 03/05/2018 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Neos Therapeutics, Inc.|
Txns:
| Granted 18,750 shares
@ $0
Granted 56,250 options to buy
@ $8.3, valued at
$466.9k
|
|
| 05/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/25/2016 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Neos Therapeutics, Inc.|
Txns:
| Bought 3,710 shares
@ $6.815, valued at
$25.3k
|
|
| 04/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/09/2012 |
4
| Eisenstadt Richard I (VP, Finance & CFO) has filed a Form 4 on TRANZYME INC|
Txns:
| Granted 40,000 options to buy
@ $4.24, valued at
$169.6k
|
|
| 04/21/2011 |
4
| Eisenstadt Richard I (VP, Finance & C.F.O.) has filed a Form 4 on TRANZYME INC|
Txns:
| Granted 148,736 options to buy
@ $4, valued at
$594.9k
|
|